Arcus biosciences to participate in the goldman sachs 45th annual global healthcare conference

Hayward, calif.--(business wire)--arcus biosciences (nyse:rcus), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in a fireside chat at the upcoming goldman sachs 45th annual global healthcare conference in miami beach, fl. the fireside chat will take place on wednesday, june 12th, 2024 at 10:00am et. a live webcast of the fireside chat will be a.
RCUS Ratings Summary
RCUS Quant Ranking